VNRX
VolitionrxยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VNRX Profile
Volitionrx Limited
A developer of blood-based diagnostic tests used for detecting and diagnosing cancer
Healthcare Equipment and Supplies
09/24/1998
02/06/2015
American Stock Exchange
85
12-31
Common stock
1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014
--
Volitionrx Limited was incorporated under the laws of the State of Delaware on September 24, 1998. The company is a clinical-stage life sciences company dedicated to developing blood-based diagnostic tests for the detection and diagnosis of cancer and other diseases to meet the needs of accurate, fast, inexpensive, scalable diagnostic tests. To date, the company has developed 20 blood assays using its Nucleosomics biomarker-based technology platform, which can be used alone or in combination to generate cancer-specific blood test-based profiles.
